Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4M Sell
153,355
-18,108
-11% -$4.81M 0.01% 638
2026
Q1
$25.9M Sell
171,463
-46,226
-21% -$5.61M 0.01% 796
2025
Q4
$23.8M Buy
+217,689
New +$31.7M 0.01% 799
2025
Q3
Sell
-4,890
Closed -$791K 2295
2025
Q2
$791K Hold
4,890
﹤0.01% 2435
2025
Q1
$522K Sell
4,890
-106,210
-96% -$14.8M ﹤0.01% 2495
2024
Q4
$13.7M Buy
111,100
+104,550
+1,596% +$14.7M ﹤0.01% 1110
2024
Q3
$937K Buy
6,550
+2,900
+79% +$412K ﹤0.01% 2427
2024
Q2
$597K Buy
+3,650
New +$454K ﹤0.01% 2584

Other funds holding ARM

UBS AM's ARM Position: Q2 2026 in Review

UBS AM reduced its Arm (ARM) stake by 11% in Q2 2026, selling an estimated $4.81M and leaving 153,355 shares worth $54.4M. The position accounts for 0.01% of the portfolio, ranked #638.

UBS AM first reported a position in ARM in Q2 2024 and has held it in 8 quarters since. 955 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • UBS AM held 153,355 shares of Arm worth $54.4M as of Q2 2026.
  • UBS AM sold 18,108 Arm shares in Q2 2026, an estimated $4.81M.
  • Arm made up 0.01% of UBS AM's portfolio in Q2 2026, its #638 holding.
  • UBS AM first reported a position in Arm in Q2 2024 and has held it in 8 quarters since.
  • 955 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.